Prevention of influenza among travellers attending at a UK travel clinic: Beliefs and perceptions. A cross-sectional study

Influenza and other Respiratory Viruses

Volumn 7, Issue 4, 2013, Pages 574-583

  Masuet Aumatell, Cristina ^a   Toovey, Stephen ^b   Zuckerman, Jane N ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Antiviral drugs; Belief; Influenza; Perception; Travellers

Indexed keywords

ANTIMALARIAL AGENT; ANTIVIRUS AGENT; INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADULT; AGED; ARTICLE; BEHAVIOR; CROSS-SECTIONAL STUDY; DOUBLE BLIND PROCEDURE; DRUG UPTAKE; FEMALE; HEALTH BELIEF; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; TRAVEL; UNITED KINGDOM; VALIDITY;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LONDON; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; TRAVEL; TRAVEL MEDICINE; YOUNG ADULT;

EID: 84879095407     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12010     Document Type: Article

References (51)

1. Leder K, Sundararajan V, Weld L, Pandey P, Brown G, Torresi J. GeoSentinel Surveillance Group Respiratory tract infections in travelers: a review of the GeoSentinel surveillance network. Clin Infect Dis 2003; 36:399-406.
2. Marti F, Steffen R, Mutsch M. Influenza vaccine: a travelers' vaccine?Expert Rev Vaccines 2008; 7:679-687.
3. Gautret P, Schlagenhauf P, Gaudart J et al. ; GeoSentinel Surveillance Network. Multicenter EuroTravNet/Geo. Sentinel study of travel-related infectious diseases in Europe. Emerg Infect Dis. 2009;15:1783-1790.
4. Mutsch M, Tavernini M, Marx A et al. Influenza virus infection in travelers to tropical and subtropical countries. Clin Infect Dis 2005; 40:1282-1287.
5. Wilder-Smith A (2006) Tourism and SARS; in Wilks J, Pendergast D, Leggat P (eds): Tourism in Turbulent Times: Towards Safe Experiences for Visitors. London: Elsevier, 2006; 53-62.
6. Brownstein JS, Wolfe CJ, Mandl KD. Empirical evidence for the effect of airline travel on the inter-regional influenza spread in the United States. PLoS Med 2006; 3:1826-1835.
7. Khan K, Arino J, Hu W et al. Spread of a novel influenza A (H1N1) virus via global airline transportation. N Engl J Med 2009; 361:212-214.
8. Goubar A, Bitar D, Cao WC, Feng D, Fang LQ, Desenclos JC. An approach to estimate the number of SARS cases imported by international air travel. Epidemiol Infect 2009; 137:1019-1031.
9. Boggild AK, Castelli F, Gautret P et al. Vaccine-preventable diseases in returned international travelers: results from the GeoSentinel Surveillance Network. Vaccine 2010; 28:7389-7395.
10. Yanni EA, Marano N, Han P et al. Knowledge, attitudes, and practices of US travelers to Asia regarding seasonal influenza and H5N1 avian influenza prevention measures. J Travel Med 2010; 17:374-381.
11. Leggat PA. Risk assessment in travel medicine. Travel Med Infect Dis 2006; 4:127-134.
12. Cooper DL, Smith GE, Edmunds WJ, Joseph C, Gerard E, George RC. The contribution of respiratory pathogens to the seasonality of NHS direct calls. J Infect 2007; 55:240-248.
13. Shek LP, Lee BW. Epidemiology and seasonality of respiratory tract virus infections in the tropics. Paediatr Respir Rev 2003; 4:105-111.
14. Tang JW, Ngai KL, Lam WY, Chan PK. Seasonality of influenza A(H3N2) virus: a Hong Kong perspective (1997-2006). PLoS ONE 2008; 3:e2768.
15. Moura FE. Influenza in the tropics. Curr Opin Infect Dis 2010; 23:415-420.
16. Leo YS, Lye DC, Chow A. Influenza in the tropics. Lancet Infect Dis 2009; 9:457-458.
17. Lowen A, Palese P. Transmission of influenza virus in temperate zones is predominantly by aerosol, in the tropics by contact: a hypothesis. PLoS Curr 2009; 1:RRN1002.
18. Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007; 25:6852-6862.
19. de Jong JC, Beyer WE, Palache AM, Rimmelzwaan GF, Osterhaus AD. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol 2000; 61:94-99.
20. Moura FE, Perdigão AC, Siqueira MM. Seasonality of influenza in the tropics: a distinct pattern in northeastern Brazil. Am J Trop Med Hyg 2009; 81:180-183.
21. Centers for Disease Control and Prevention. Use of northern hemisphere influenza vaccines by travelers to the southern hemisphere. MMWR Morb Mortal Wkly Rep 2009; 58:312.
22. Rashid H, Shafi S, Haworth E et al. Influenza vaccine in Hajj pilgrims: policy issues from field studies. Vaccine 2008; 26:4809-4812.
23. Rashid H, Shafi S, Haworth E et al. Viral respiratory infections at the Hajj. Comparison between UK and Saudi pilgrims. Clin Microbiol Infect 2008; 14:569-574.
24. Alborzi A, Aelami MH, Ziyaeyan M et al. Viral etiology of acute respiratory infections among Iranian Hajj pilgrims 2006. J Travel Med 2009; 16:239-242.
25. Asklin H, Rombo L. Influenza in travellers. Curr Opin Infect Dis 2010; 23:421-425.
26. World Health Organization. International travel and health. 2010 Available at http://www.who.int/ith/ITH2010chapter6 (Accessed 4 October 2010.)
27. World Health Organization. World now at the start of 2009 influenza pandemic. Available at http://bit.ly/bZBUkS (Accessed 4 October 2010.)
28. National Travel Health Network and Centre (2009) Clinical updates: pandemic (H1N1) 2009 influenza: update 21: current status of the pandemic. Available at http://bit.ly/dy85HV (Accessed 4 October 2010.)
29. Centers for Disease Control and Prevention. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2008; 57 (No. RR-7): 1-60.
30. Aoki FY, Macleod MD, Paggiaro P et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 2003; 51:123-129.
31. Sheeran P, Conner M, Norman P. Can the theory of planned behaviour explain patterns of health behavior change?Health Psychol 2001; 20:12-19.
32. Ajzen I, Fishbein M. Understanding Attitudes and Predicting Social Behavior. Englewood Cliffs, NJ: Prentice Hall, 1980.
33. Fogarty AS, Holland K, Imison M, Blood RW, Chapman S, Holding S. Communicating uncertainty - how Australian television reported H1N1 risk in 2009: a content analysis. BMC Public Health 2011; 11:181.
34. Martin T. [Pandemic as a communication challenge for the governmental authorities-an overview of the governmental public relations measures for the new influenza ("swine flu"). Basic communication features]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2010; 53:1304-1307. German.
35. Rubin GJ, Potts HW, Michie S. The impact of communications about swine flu (influenza A H1N1v) on public responses to the outbreak: results from 36 national telephone surveys in the UK. Health Technol Assess 2010; 14:183-266.
36. Simonsen KA, Hunskaar S, Wensaas KA et al. Influenza-like illness in general practice in Norway: clinical course and attitudes towards vaccination and preventive measures during the 2009 pandemic. Fam Pract. 29:139-146.
37. Liao Q, Cowling BJ, Lam WW, Fielding R. Factors affecting intention to receive and self-reported receipt of 2009 pandemic (H1N1) vaccine in Hong Kong: a longitudinal study. PLoS ONE 2011; 6:e17713.
38. Mitchell T, Dee DL, Phares CR et al. Non-pharmaceutical interventions during an outbreak of 2009 pandemic influenza A (H1N1) virus infection at a large public university, April-May 2009. Clin Infect Dis 2011; 52(Suppl 1):S138-S145.
39. Suess T, Remschmidt C, Schink S et al. Facemasks and intensified hand hygiene in a German household trial during the2009/2010 influenza A(H1N1) pandemic: adherence and tolerability in children and adults. Epidemiol Infect 2011; 139:1895-1901.
40. Blank PR, Freiburghaus AU, Schwenkglenks M, Szucs TD. Trends in influenza vaccination coverage rates in the United Kingdom over six seasons from 2001-2 to 2006-7. Euro Surveill 2008; 13:1-7.
41. Pfeil A, Mutsch M, Hatz C, Szucs TD. A cross-sectional survey to evaluate knowledge, attitudes and practices (KAP) regarding seasonal influenza vaccination among European travelers to resource-limited destinations. BMC Public Health 2010; 10:402-408.
42. Helfenberger S, Tschopp A, Robyn L, Hatz C, Schlagenhauf P. Knowledge, attitudes, and practices of business travelers regarding influenza and the use of antiviral medication. J Travel Med 2010; 17:367-373.
43. Smith JR, Rayner CR, Donner B, Wollenhaupt M, Klumpp K, Dutkowski R. Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience. Adv Ther 2011; 28:927-959.
44. Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire Int 2006; 15:21-30.
45. Centers for Disease Control and Prevention. Infectious disease. Antiviral agents for the treatment and chemoprophylaxis of influenza. Ann Emerg Med 2011; 58:299-303; discussion 303-304.
46. Marathe A, Lewis B, Barrett C et al. Comparing effectiveness of top-down and bottom-up strategies in containing influenza. PLoS ONE 2011; 6:e25149.
47. Bannister B, Hatz C, Toovey S, Price R, Zuckerman JN. The role of standby emergency medication for falciparum malaria: current opinion. Travel Med Infect Dis 2004; 2:119-126.
48. Adisasmito W, Chan PK, Lee N et al. Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry. J Infect Dis 2010; 202:1154-1160.
49. Gasink LB, Linkin DR, Fishman NO, Bilker WB, Weiner MG, Lautenbach E. Stockpiling drugs for an avian influenza outbreak: examining the surge in oseltamivir prescriptions during heightened media coverage of the potential for a worldwide pandemic. Infect Control Hosp Epidemiol 2009; 30:370-376.
50. Aro AR, Vartti AM, Schreck M, Turtianen P, Uutela A. Willingness to take travel-related health risks-a study among Finnish tourists in Asia during the avian Influenza outbreak. Int J Behav Med 2009; 16:68-73.
51. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM; Centers for Disease Control and Prevention (CDC). Antiviral agents for the treatment and chemoprophylaxis of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR January 21, 2011 / 60(RR01); 1-24.